EP Patent

EP2534153B1 — Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one

Assigned to Pfizer Inc · Expires 2016-09-21 · 10y expired

What this patent protects

Patent listed against rucaparib-camsylate.

Drugs covered by this patent

Patent Metadata

Patent number
EP2534153B1
Jurisdiction
EP
Classification
—
Expires
2016-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.